Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Should You Buy Symbotic Stock After the Spectacular Investor Update?
Symbotic (NASDAQ: SYM) uses robotics technology to automate warehouse operations.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »*Stock prices used were the afternoon prices of Nov. 26, 2025. The video was publishe...
The Motley Fool
Mon, Dec 1
2 Best Artificial Intelligence Stocks to Buy in December
Key PointsNvidia sees monster growth over the next few years.Taiwan Semiconductor is supplying the chips for artificial intelligence (AI) computing providers. 10 stocks we like better than Nvidia › The artificial intelligence (AI) investment trend seemed to be on its way out in the middle of Novembe...
The Motley Fool
Mon, Dec 1
Why Has Nvidia Stock Soared?
Investors have been rewarded for owning Nvidia (NASDAQ: NVDA) stock over the years.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »*Stock prices used were the afternoon prices of Nov. 26, 2025. The video was publis...
The Motley Fool
Mon, Dec 1
Ideaya rises as FDA clears trial for experimental cancer drug
Shares of California-based drug developer Ideaya Biosciences IDYA.O rise 3.3% to $36.80 premarket Co says it has received clearance from U.S. FDA to begin its first human trial on its new experimental cancer drug, IDE034, which is designed to target several common types of solid tumorsDrug targe...
Reuters
Mon, Dec 1
3 High-Yield Dividend Stocks I'm Buying to Boost My Passive Income in December
Key PointsMedical Properties Trust is finally healthy again. Mid-America Apartment Communities expects its earnings growth rate to start accelerating next year. W.P. Carey has been rebuilding its portfolio and dividend. 10 stocks we like better than Medical Properties Trust › I set a goal at the beg...
The Motley Fool
Mon, Dec 1
Should You Buy UiPath Stock Before the Huge Investor Update?
UiPath (NYSE: PATH) is scheduled to report quarterly financial results on Dec. 3, 2025, which could have huge implications for investors.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »*Stock prices used were the a...
The Motley Fool
Mon, Dec 1
Strategy Announces Establishment of $1.44 Billion USD Reserve and Updates FY 2025 Guidance
Strategy today announced the establishment of a US dollar reserve (“USD Reserve”) of $1.44 billion and updates to its assumptions underlying its previously issued forward guidance and bitcoin key performance indicator (“KPI”) targets for the fiscal year ending December 31, 2025, which were published...
Tiger News
Mon, Dec 1
Prediction: One of These Two AI Stocks Could Soar 50% by 2026
In this analysis, I reveal why Palantir (NASDAQ: PLTR) continues capturing explosive AI-driven growth while Microsoft (NASDAQ: MSFT) delivers unmatched stability backed by recurring enterprise revenue. You'll uncover the catalysts, risks, and upside scenarios shaping both companies, and which one ma...
The Motley Fool
Mon, Dec 1
Synopsys jumps on Nvidia's $2 billion investment
Chip design software provider Synopsys' SNPS.O shares rise 7.8% to $450.63 premarketChipmaker Nvidia invests $2 bln in SNPS at $414.79 per shareInvestment adds to NVDA's tie-ups in the AI ecosystem amid concerns about circular dealsUp to last close, SNPS has fallen 13.9% this year
Reuters
Mon, Dec 1
Credo vs. Astera: Which Could Be the Next Big AI Winners
Credo Technology (NASDAQ: CRDO) and Astera Labs (NASDAQ: ALAB) are emerging as two of the most exciting plays in the artificial intelligence (AI) data-center revolution. With explosive revenue growth, rising profitability, and ambitious long-term guidance, both companies could benefit massively from...
The Motley Fool
Mon, Dec 1
Cybersecurity Spending Set to Surge 73%: 1 Best-In-Breed Stock to Take Advantage
Key PointsCrowdStrike disrupted the cybersecurity market with its cloud-native services.Its growth should accelerate and stabilize again over the next few years.Its stock isn’t cheap, but its “best in breed” reputation justifies its premium valuation.10 stocks we like better than CrowdStrike › The c...
The Motley Fool
Mon, Dec 1
Daré Bioscience rises as Bayer exits Ovaprene partnership deal
Shares of women's health firm Daré Bioscience DARE.O rise 6% to $1.91 premarketCo says it will regain full rights to its experimental contraceptive ovaprene after Bayer HealthCare decided to end its partnership with the U.S. biotech firmThe move gives Daré control over ovaprene as it enters late...
Reuters
Mon, Dec 1
Strategy slips as bitcoin selloff prompts sharp forecast cut
Shares of bitcoin buyer Strategy MSTR.O drop 4.6% to $169.33 premarketCo slashes 2025 earnings forecast after massive drop in bitcoin pricesMSTR's updated 2025 outlook ranges from a loss of $17 per share to a profit of $19 per share, compared with its previous forecast of $80 per share profitAls...
Reuters
Mon, Dec 1
Accenture rises on OpenAI tie-up
Shares of IT consulting firm Accenture ACN.N rise 4.8% to $262 premarket Accenture announced tie-up with OpenAI that will equip professionals with ChatGPT Enterprise and help OpenAI scale its capabilities to enterprisesCo says OpenAI will be one of its primary AI partners for its next generation of ...
Reuters
Mon, Dec 1
Belite Bio surges after eye drug meets main goal in late-stage study
Shares of drug developer Belite Bio BLTE.O rise 17.9% to $162 premarketStock on track to open at record highs, if gains hold Co's genetic eye disease drug meets main goal in late-stage studyThe drug, tinlarebant, targets a progressive eye disease causing vision loss in childhood or adolescenceTh...
Reuters
Mon, Dec 1
The Single Most Common Retirement Planning Mistake People Make in Their 50s
Key PointsIt's vital to plan for your retirement, long before you retire.Ideally, you should aim to have multiple income streams.Estimate your future expenses carefully and comprehensively.The $23,760 Social Security bonus most retirees completely overlook › What's the single most common retirement ...
The Motley Fool
Mon, Dec 1
BMO lifts Old Dominion Freight Line to 'outperform', slashes PT
BMO upgrades U.S. trucking firm Old Dominion Freight Line ODFL.O to "outperform" from "market perform"However, cuts PT to $170 from $172, still implying an upside of 25.7% from the stock's last closeBrokerage says co's disciplined execution, strong pricing power, and robust c...
Reuters
Mon, Dec 1
Utility Exelon drops after announcing $900 mln convertible debt offering
Shares of electric utility Exelon EXC.O down 1.3% premarket to $46.50 as it seeks capital Chicago, Illinois-based EXC announces private offering of $900 mln convertible bonds due 2029 Co plans to use net offering proceeds to repay or refinance debt, or for general corp purposesEXC has roughly ...
Reuters
Mon, Dec 1
Goldman Sachs to buy ETF sponsor Innovator in $2 billion cash-and-stock deal
Dec 1 (Reuters) - Goldman Sachs GS.N said on Monday it will buy active exchange-traded fund sponsor Innovator Capital Management in a cash-and-stock deal worth about $2 billion, as the Wall Street bank seeks to expand in one of the fastest-growing asset management segments.Active funds have regained...
Reuters
Mon, Dec 1
If You'd Invested $1,000 in the Technology Select Sector SPDR Fund (XLK) 10 Years Ago, Here's How Much You'd Have Today
Key PointsStocks in the Technology Select Sector SPDR Fund (XLK) include Nvidia and Microsoft.These stocks now consume a large portion of the broader benchmark S&P 500 index.They are responsible for driving the market higher over the past three years.10 stocks we like better than Select Sector SPDR ...
The Motley Fool
Mon, Dec 1
1
...
185
186
187
187
/
300
188
189
...
300
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up